These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11275736)

  • 1. Lower urinary tract symptoms suggestive of benign prostatic obstruction: what is the available evidence for rational management?
    Speakman MJ
    Eur Urol; 2001; 39 Suppl 3():6-12. PubMed ID: 11275736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower urinary tract symptoms suggestive of benign prostatic obstruction--what's the long-term effectiveness of medical therapies?
    Michel MC; Goepel M
    Eur Urol; 2001; 39 Suppl 3():20-5. PubMed ID: 11275738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the current practice patterns?
    McNicholas TA
    Eur Urol; 2001; 39 Suppl 3():26-30. PubMed ID: 11275739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower urinary tract symptoms suggestive of benign prostatic obstruction: how can clinical expertise contribute to rational management?
    Stoevelaar HJ; McDonnell J; Bosch JL; Kahan JP;
    Eur Urol; 2001; 39 Suppl 3():13-9. PubMed ID: 11275737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: design and implementation.
    Chapple CR
    Eur Urol; 2001; 39 Suppl 3():31-6. PubMed ID: 11275740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: health-economical analysis.
    McDonnell J; Busschbach JJ; Kok E; van Exel J; Stolk E; Koopmanschap M; Rutten FF
    Eur Urol; 2001; 39 Suppl 3():37-41. PubMed ID: 11275741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: the role of general practice databases.
    Logie JW; Clifford GM; Farmer RD; Meesen BP
    Eur Urol; 2001; 39 Suppl 3():42-7. PubMed ID: 11275742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review.
    De Nunzio C; Presicce F; Lombardo R; Trucchi A; Bellangino M; Tubaro A; Moja E
    BMC Urol; 2018 Jun; 18(1):62. PubMed ID: 29940928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond medications: office-based procedures for benign prostatic obstruction.
    Tran PU; Chung ASJ
    World J Urol; 2019 Jun; 37(6):1023-1027. PubMed ID: 31037402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction and conclusions. Improving the management of lower urinary tract symptoms in real life practices.
    Chapple CR
    Eur Urol; 2001; 39 Suppl 3():1-5. PubMed ID: 11275735
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials?
    Zimmern P
    Eur Urol; 2000; 38 Suppl 1():18-24. PubMed ID: 11111205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of prostatic obstruction with urethral stents.
    Peyton CC; Badlani GH
    Can J Urol; 2015 Oct; 22 Suppl 1():75-81. PubMed ID: 26497347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Djavan B; Marberger M
    Eur Urol; 1999; 36(1):1-13. PubMed ID: 10364649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are lower urinary tract symptoms managed in real life practice? The French experience.
    Vallancien G
    Eur Urol; 2000; 38 Suppl 1():54-9. PubMed ID: 11111209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic stents for benign prostatic hyperplasia.
    Klein LT; Kaplan SA
    J Long Term Eff Med Implants; 1997; 7(1):101-14. PubMed ID: 10168540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The valuation of the International Prostate Symptom Score (IPSS) for use in economic evaluations.
    Kok ET; McDonnell J; Stolk EA; Stoevelaar HJ; Busschbach JJ; ;
    Eur Urol; 2002 Nov; 42(5):491-7. PubMed ID: 12429159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging treatment options for benign prostatic obstruction.
    Parsons BA; Hashim H
    Curr Urol Rep; 2011 Aug; 12(4):247-54. PubMed ID: 21475952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-blocker therapy for lower urinary tract symptoms suggestive of benign prostatic obstruction: what are the relevant differences in randomised controlled trials?
    De Mey C
    Eur Urol; 2000; 38 Suppl 1():25-39. PubMed ID: 11111206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.